PAD: Medtronic launches Entrust delivery device

Medtronic (NYSE:MDT) said today it launched the Entrust delivery system in the U.S., designed to work with the company’s EverFlex self-expanding peripheral stent for treating peripheral arterial disease.

The system allows operating physicians to maintain a low profile while deploying the stent to re-open stenotic regions in the superficial femoral and proximal popliteal arteries that supply blood to the legs, Finley, Minn.-based Medtronic said.

“The Entrust delivery system allows me to confidently deliver the EverFlex stent with control and ease, ensuring precise placement of the stent even in difficult, complex or hard to reach lesions,” Dr. George Meier of Ohio’s University of Cincinnati Medical Center said in a press release.

The Entrust has a 5 F triaxial delivery system and is compatible with 0.035″ guidewires and long catheter lengths, the company said,

“The Entrust delivery system is a great example of how industry and physicians can partner to deliver game-changing technology. The low profile, long catheter option, and 1-handed, triaxial delivery system put the Entrust delivery system in a class of its own when it comes to peripheral vascular stents,” Dr. Luke Marone of the UPMC Passavant Hospital said in prepared remarks.

“Based on physician feedback and procedural observation, we developed an easy to use one-handed delivery system to increase the stent delivery options in our portfolio. Both the Entrust delivery system and the EverFlex stent with the pin-pull delivery system provide enhanced choice and treatment solutions for peripheral arterial disease,” Medtronic peripheral vascular veep Brian Verrier said in a press release.

In April, Medtronic reported solid 3-year results for the EverFlex self-expanding peripheral stent system it picked up when it paid $50 billion for Covidien in January. The global medical device giant said 3-year results from the Durability II study of Everflex showed the single-stent treatment had sustained effect in addressing long, complex lesions in the superficial femoral and popliteal arteries and keeping them unobstructed.

The post PAD: Medtronic launches Entrust delivery device appeared first on MassDevice.

from MassDevice http://ift.tt/1UqiSmW